Withdrawn in the United Kingdom due to risk of psychiatric adverse drug reactions. This drug continues to be available in the U.S. Internationally, triazolam is a Schedule IV drug under the Convention on Psychotropic Substances.
For the short-term treatment of insomnia.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.